New Designer Drugs

M. Levine; F. Lovecchio

doi:10.1016/j.emc.2021.04.013

Back

Journal article

Peer reviewed

New Designer Drugs

M. Levine and F. Lovecchio

Emergency medicine clinics of North America, Vol.39(3), pp.677-687

2021

DOI: https://doi.org/10.1016/j.emc.2021.04.013

Abstract

Novel drugs

Opiates

Overdose

Phenethylamine

Toxicology

buprenorphine

cannabis

designer drug

fentanyl

fentanyl derivative

hypnotic agent

illicit drug

loperamide

opiate

cannabinoid

hypnotic sedative agent

naloxone

narcotic analgesic agent

narcotic antagonist

phenethylamine derivative

disease association

drug abuse

drug classification

drug exposure

drug legislation

drug overdose

human

Mitragyna speciosa

obstructive jaundice

opiate addiction

QRS interval

QT prolongation

Review

adverse event

complication

drug dependence

Mitragyna

Analgesics, Opioid

Cannabinoids

Designer Drugs

Humans

Hypnotics and Sedatives

Illicit Drugs

Narcotic Antagonists

Phenethylamines

Substance-Related Disorders

Files and links (1)

url

https://www.scopus.com/inward/record.uri?eid=2-s2.0-85107700114&doi=10.1016%2fj.emc.2021.04.013&partnerID=40&md5=1a16677f251850182774a62bf197fa39View

Metrics

1 Record Views

See more details

Details

Title: New Designer Drugs
Creators: M. Levine - University of California, Los Angeles
F. Lovecchio - Arizona State University
Publication Details: Emergency medicine clinics of North America, Vol.39(3), pp.677-687
Publisher: W.B. Saunders
Identifiers: 991006028698002656
Academic Unit: Emergency Medicine
Language: English
Resource Type: Journal article